|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 601 13th St., NW |
Address2 |
|
| City | Washington |
State | DC |
Zip Code | 20005-2000 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46676-12
|
||||||||
|
6. House ID# 395790000
|
||||||||
| TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: AMY E. MODLIN |
Date | 7/20/2021 1:13:29 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Lower Health Care Costs; Transparency; Surprise Billing, Maternal Health; COVID-19 Response/Relief Packages, Telehealth/ Audio-Only; COVID-19 ; Black Maternal Health; Age adjustment; Health disparities; Implementation timetables/deliverables; Health Equities; SEP; Modeling of BCBSA Individual Market Proposals; CAA; APCD; Closing Coverage Gap; Extending Exchange Subsidies; Health Equity Issues;
Public Law 116-260 (H.R. 133)
Covid-19 Relief and Fiscal 2021 Omnibus Consolidated Appropriations Act, 2021 Sponsor: Rep. Henry Cuellar (D-TX-28)
H.R. 19 - Lower Costs, More Cures Act of 2021 Sponsor: Rep. Cathy McMorris Rodgers (R-WA-05)
H.R. 2503 - Social Determinants Accelerator Act of 2021 Sponsor: Rep. Cheri Bustos (D-IL-17)
H.R. 3969 - To amend title XXVII of the Public Health Service Act to include activities to address social determinants of health in the calculation of medical loss ratios.
Sponsor: Rep. John Curtis (R-UT-03)
Public Law 117-2 (H.R. 1319) - American Rescue Plan Act of 2021 Sponsor: Rep. John Yarmuth (D-KY-03)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicaid Maternal Health; Medicare Advantage Audio Only; Medicare; Medicare Advantage Reform; Medicaid; Part D Reform;
S. 150 - Ensuring Parity in MA for Audio-Only Telehealth Act of 2021 Sponsor: Sen. Catherine Cortez Masto (D-NV)
Public Law 117-7 (H.R. 1868) - To prevent across-the-board direct spending cuts, and for other purposes. Sponsor: Rep. John Yarmuth (D-KY-03)
S. 4840 - Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 Sponsor: Sen. Pat Roberts (R-KS)
H.R. 7659 - Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 2166 - To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans and PACE programs, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021 Sponsor: Rep. David McKinley (R-WV-01)
H.R. 2166 - Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021 Sponsor: Rep. Terri Sewell (D-AL-07)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
ACA Tax Credits; APTC;
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes. Sponsor: Rep. John Yarmuth (D-KY-03)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx reform; Prescription drugs; Prescription Drug Reform;
H.R. 951 - Maternal Vaccination Act Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 979 - Vaccine Fairness Act Sponsor: Rep. Angie Craig (D-MN-02)
H.R. 1452 - To direct the Secretary of Health and Human Services to publish the formula the Secretary uses to determine the allocation of COVID-19 vaccines, and for other purposes.
Sponsor: Rep. Dan Crenshaw (R-TX-02)
H.R. 1978 - Protecting Seniors Through Immunization Act of 2021 Sponsor: Rep. Annie Kuster (D-NH-02)
H.R. 2347 - Strengthening the Vaccines for Children Program Act of 2021 Sponsor: Rep. Kim Schrier (D-WA-08)
H.R. 3013 - COVID Vaccine Transportation Access Act Sponsor: Rep. Nanette Barragan (D-CA-44)
H.R. 3655 - Vaccine Injury Compensation Modernization Act of 2021 Sponsor: Rep. Lloyd Doggett (D-TX-35)
H.R. 3742 - Vaccine INFO Act Sponsor: Rep. Gus Bilirakis (R-FL-12)
H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone (D-NJ-06)
H.R. 2831 - Prompt Approval of Safe Generic Drugs Act Sponsor: Rep. Nanette Barragan (D-CA-44)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Postal Reform;
H.R. 3076 - Postal Service Reform Act of 2021 Sponsor: Rep. Carolyn Maloney (D-NY-12)
S. 1720 - Postal Service Reform Act of 2021 Sponsor: Sen. Gary Peters (D-MI)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Modlin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |